Ritesh R. Kotecha

2.8k total citations · 1 hit paper
81 papers, 1.7k citations indexed

About

Ritesh R. Kotecha is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Ritesh R. Kotecha has authored 81 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Pulmonary and Respiratory Medicine, 29 papers in Molecular Biology and 27 papers in Cancer Research. Recurrent topics in Ritesh R. Kotecha's work include Renal cell carcinoma treatment (48 papers), Renal and related cancers (23 papers) and Cancer Genomics and Diagnostics (22 papers). Ritesh R. Kotecha is often cited by papers focused on Renal cell carcinoma treatment (48 papers), Renal and related cancers (23 papers) and Cancer Genomics and Diagnostics (22 papers). Ritesh R. Kotecha collaborates with scholars based in United States, Japan and Spain. Ritesh R. Kotecha's co-authors include Martin H. Voss, J. Luis Espinoza, Akiyoshi Takami, A. Ari Hakimi, Robert J. Motzer, Lynda Vuong, Chung‐Han Lee, Robert Reger, Richard Childs and Mattias Carlsten and has published in prestigious journals such as Science, Journal of Clinical Oncology and Blood.

In The Last Decade

Ritesh R. Kotecha

70 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor Microenvironment Dynamics in Clear-Cell Renal Cell Carcinoma

2019 293 citations Ritesh R. Kotecha, Martin H. Voss et al. profile →

Peers

Countries citing papers authored by Ritesh R. Kotecha

Since Specialization

Citations

This map shows the geographic impact of Ritesh R. Kotecha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ritesh R. Kotecha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ritesh R. Kotecha more than expected).

Fields of papers citing papers by Ritesh R. Kotecha

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ritesh R. Kotecha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ritesh R. Kotecha. The network helps show where Ritesh R. Kotecha may publish in the future.

Co-authorship network of co-authors of Ritesh R. Kotecha

This figure shows the co-authorship network connecting the top 25 collaborators of Ritesh R. Kotecha. A scholar is included among the top collaborators of Ritesh R. Kotecha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ritesh R. Kotecha. Ritesh R. Kotecha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sensitive CAR T cells redefine targetable CD70 expression in solid tumors 2026 ·Science ·(unknown), (unknown), Michael Lopez, (unknown), (unknown), Sascha Haubner, (unknown), (unknown), Sarah Nataraj, (unknown), (unknown), Pierre-Jacques Hamard, (unknown), (unknown), (unknown), (unknown), Elisa de Stanchina, (unknown), Ritesh R. Kotecha, (unknown), (unknown), Michel Sadelain	0
2	Pathologic Response to Immunotherapy Is Associated with Survival in Patients Undergoing Delayed Nephrectomy for Metastatic Renal Cell Carcinoma 2025 ·European Urology Oncology ·Yash S. Khandwala, Stephen W. Reese, (unknown), Andrea Knežević, Lennert Eismann, Chih‐Ying Wu, (unknown), (unknown), (unknown), (unknown), Jonathan Coleman, (unknown), Robert J. Motzer, Paul Russo, Oğuz Akın, Ritesh R. Kotecha, Ying‐Bei Chen, Martin H. Voss, (unknown)	0
3	Multi-institutional Analysis of Immune-Oncology Combination Therapy for Metastatic MiT Family Translocation Renal Cell Carcinoma 2025 ·Journal of Immunotherapy ·Yasser Ged, (unknown), Luis Contreras, Roy Elias, (unknown), (unknown), Ezra Baraban, Nirmish Singla, Chung‐Han Lee, (unknown), Matthew R. Zibelman, Ritesh R. Kotecha	1
4	Sample Site Impacts RNA Biomarkers for Renal Cell Carcinoma 2024 ·European Urology ·Lennert Eismann, Amy Xie, Cerise Tang, Andrea Knežević, Irina Ostrovnaya, Fengshen Kuo, A. Ari Hakimi, Ed Reznik, Ritesh R. Kotecha	2
5	Cabozantinib Plus Nivolumab in Patients with Non–Clear Cell Renal Cell Carcinoma: Updated Results from a Phase 2 Trial 2024 ·European Urology ·Kelly N. Fitzgerald, Chung‐Han Lee, Martin H. Voss, Maria I. Carlo, Andrea Knežević, (unknown), Ying‐Bei Chen, Robert A. Lefkowitz, Neil J. Shah, Colette Owens, Deaglan Joseph McHugh, David H. Aggen, (unknown), Ritesh R. Kotecha, Darren R. Feldman, Robert J. Motzer	15
6	The Influence of Religion/Spirituality on End of Life Outcomes Among Cancer Patients of Dharmic Religions (CO301B) 2024 ·Journal of Pain and Symptom Management ·(unknown), (unknown), Danielle Boselli, (unknown), (unknown), Ritesh R. Kotecha, (unknown), Viraj V. Patel, Judith E. Nelson	0
7	Gene expression of prostate-specific membrane antigen (FOLH1) in clear cell renal cell carcinoma predicts angiogenesis and response to tyrosine kinase inhibitors 2024 ·Urologic Oncology Seminars and Original Investigations ·Sari Khaleel, Marlon Perera, Nathan Papa, Fengshen Kuo, Mahdi Golkaram, Phillip M. Rappold, Ritesh R. Kotecha, Jonathan Coleman, Paul Russo, Robert J. Motzer, Ed Reznik, A. Ari Hakimi	2
8	Clinical outcomes of sacituzumab govitecan (SG) after prior exposure to enfortumab vedotin (EV) in patients with metastatic urothelial carcinoma (mUC). 2024 ·Journal of Clinical Oncology ·(unknown), (unknown), Jeeban Paul Das, Thomas Powles, Dean F. Bajorin, Ritesh R. Kotecha, (unknown), Han Xiao, Emily Feld, Deaglan Joseph McHugh, Niamh M. Keegan, Samuel A. Funt, Neil J. Shah, Gopa Iyer, David H. Aggen, Min Yuen Teo, Irina Ostrovnaya, Jonathan E. Rosenberg	1
9	Preliminary safety, pharmacokinetics and clinical activity of DFF332, an oral HIF2α inhibitor, as monotherapy in a phase 1 dose escalation study in patients with advanced clear cell renal cell carcinoma. 2024 ·Journal of Clinical Oncology ·(unknown), Nizar M. Tannir, (unknown), Xin Gao, Ritesh R. Kotecha, Joel Picus, Filippo de Braud, Shunji Takahashi, Alvin Wong, Cristina Suárez, (unknown), (unknown), (unknown), (unknown), (unknown), Patrizia Barzaghi-Rinaudo, Laurence Albigès	4
10	Associations of dietary fructose with survival of patients (pts) with metastatic cancer of the urothelium (UC) and renal cell carcinoma (RCC) on immune checkpoint blockade (ICB). 2024 ·Journal of Clinical Oncology ·(unknown), Brendan J. Guercio, (unknown), (unknown), (unknown), (unknown), Min Yuen Teo, Ashley Marie Regazzi, (unknown), Samuel A. Funt, David H. Aggen, Martin H. Voss, (unknown), Neil J. Shah, Robert J. Motzer, Dean F. Bajorin, Jonathan E. Rosenberg, Chung‐Han Lee, Ritesh R. Kotecha, Gopa Iyer	1
11	Genomic ancestry in kidney cancer: Correlations with clinical and molecular features 2023 ·Cancer ·Ritesh R. Kotecha, Andrea Knežević, Kanika Arora, Chaitanya Bandlamudi, Fengshen Kuo, Maria I. Carlo, Kelly Fitzgerald, Darren R. Feldman, Neil J. Shah, Ed Reznik, A. Ari Hakimi, Jian Carrot‐Zhang, Diana Mandelker, Michael F. Berger, Chung‐Han Lee, Robert J. Motzer, Martin H. Voss	5
12	Immunometabolic coevolution defines unique microenvironmental niches in ccRCC 2023 ·Cell Metabolism ·Cerise Tang, Amy Xie, Eric Minwei Liu, Fengshen Kuo, Min‐Soo Kim, Renzo G. DiNatale, Mahdi Golkaram, Ying‐Bei Chen, Sounak Gupta, Robert J. Motzer, Paul Russo, Jonathan Coleman, Maria I. Carlo, Martin H. Voss, Ritesh R. Kotecha, Chung‐Han Lee, Wesley Tansey, Nikolaus Schultz, A. Ari Hakimi, Ed Reznik	14
13	Functional and translational consequences of immunometabolic coevolution in ccRCC 2023 ·The Oncologist ·Ed Reznik, Cerise Tang, Amy Xie, Eric Minwei Liu, Fengshen Kuo, Min‐Soo Kim, Mahdi Golkaram, Ying‐Bei Chen, Sounak Gupta, Robert J. Motzer, Paul Russo, Jonathan Coleman, (unknown), Martin H. Voss, Ritesh R. Kotecha, Chung‐Han Lee, Wesley Tansey, Nikolaus Schultz, A. Ari Hakimi	1
14	Associations between Pretreatment Body Composition Features and Clinical Outcomes among Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Blockade 2022 ·Clinical Cancer Research ·Yasser Ged, Alejandro Sánchez, Sujata Patil, Andrea Knežević, (unknown), Stacey Petruzella, Kate Weiss, (unknown), Joshua Chaim, Oğuz Akın, Marina Mourtzakis, Michael T. Paris, Jessica M. Scott, Fengshen Kuo, Ritesh R. Kotecha, A. Ari Hakimi, Chung‐Han Lee, Robert J. Motzer, Martin H. Voss, Helena Furberg	20
15	Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non–Clear-Cell Renal Cell Carcinoma and Genomic Correlates 2022 ·Journal of Clinical Oncology ·Chung‐Han Lee, Martin H. Voss, Maria I. Carlo, Ying‐Bei Chen, Mark Zucker, Andrea Knežević, Robert A. Lefkowitz, Natalie Shapnik, (unknown), Ed Reznik, Neil J. Shah, Colette Owens, Deaglan Joseph McHugh, David H. Aggen, (unknown), Ritesh R. Kotecha, Darren R. Feldman, Robert J. Motzer	105
16	Deciphering radiological stable disease to immune checkpoint inhibitors 2022 ·Annals of Oncology ·Jia Luo, Song Wu, Hira Rizvi, (unknown), Jacklynn V. Egger, Juan C. Osorio, Adam J. Schoenfeld, Andrew J. Plodkowski, Michelle S. Ginsberg, (unknown), Colleen Maher, Alexander N. Shoushtari, Michael A. Postow, Martin H. Voss, Ritesh R. Kotecha, Amod Gupta, Rajiv Raja, Mark G. Kris, Matthew D. Hellmann	24
17	Genomic and Metabolic Hallmarks of SDH- and FH-deficient Renal Cell Carcinomas 2022 ·European Urology Focus ·(unknown), Cerise Tang, Mark Zucker, Kelly N. Fitzgerald, Renzo G. DiNatale, Phillip M. Rappold, Kate Weiss, (unknown), Chung‐Han Lee, Nikolaus Schultz, Robert J. Motzer, Paul Russo, Jonathan Coleman, Victor E. Reuter, Ying‐Bei Chen, Maria I. Carlo, Anthony J. Gill, Ritesh R. Kotecha, A. Ari Hakimi, Ed Reznik	17
18	Combined haploidentical and cord blood transplantation for refractory severe aplastic anaemia and hypoplastic myelodysplastic syndrome 2021 ·British Journal of Haematology ·Richard Childs, Xin Tian, (unknown), Enkhtsetseg Purev, Ritesh R. Kotecha, Mattias Carlsten, Joseph Clara, Willy A. Flegel, Sharon Adams, Hanh Khuu, David F. Stroncek, Lisa Cook, Tatyana Worthy, Nancy L. Geller, (unknown), Jennifer Wilder, Robert Reger, Georg Aue	4
19	A qualitative framework of non-selection factors for cytoreductive nephrectomy 2021 ·World Journal of Urology ·Andrew W. Silagy, Kyrollis Attalla, Renzo G. DiNatale, Kate Weiss, Stanley Weng, Roy Mano, (unknown), Julian Marcon, Ed Reznik, Ritesh R. Kotecha, Robert J. Motzer, Martin H. Voss, Jonathan Coleman, A. Ari Hakimi, Paul Russo	3
20	Checkpoint Inhibition of KIR2D with the Monoclonal Antibody IPH2101 Induces Contraction and Hyporesponsiveness of NK Cells in Patients with Myeloma 2016 ·Clinical Cancer Research ·Mattias Carlsten, Neha Korde, Ritesh R. Kotecha, Robert Reger, (unknown), Dickran Kazandjian, Ola Landgren, Richard Childs	134

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xuejun Hu Breakdown of academic impact, for papers by Yanqing Li Breakdown of academic impact, for papers by Changhua Zhang Breakdown of academic impact, for papers by Jie Huang Breakdown of academic impact, for papers by Yuqin Yao Breakdown of academic impact, for papers by Yuping Yin Breakdown of academic impact, for papers by Bibo Tan